Literature DB >> 16586352

Tbx1 is expressed at multiple sites of epithelial-mesenchymal interaction during early development of the facial complex.

Maria Zoupa1, Maisa Seppala, Thimios Mitsiadis, Martyn T Cobourne.   

Abstract

TBX1 encodes a T-box-containing transcription factor, which is thought to be a key player in the aetiology of the DiGeorge and Velocardiofacial syndromes (DGS/VCFS). In addition to defects affecting structures derived from the pharyngeal pouches, these patients exhibit varying degrees of facial dysmorphology and cleft palate. We have analysed the expression of murine Tbx1 during early facial development and found transcripts at sites of known epithelial-mesenchymal interaction. In particular, Tbx1 was expressed in epithelium of the early facial processes, including the fronto-nasal, medial and lateral nasal and palatine. Transcripts were also localised to the epithelium of developing tooth germs and hair follicles at several stages during their early development. Together, these expression domains suggest a role for Tbx1 in mediating epithelial-mesenchymal signalling in regions of the developing face, a finding which is consistent with the spectrum of facial deformity encountered amongst subjects affected by DGS/VCFS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16586352     DOI: 10.1387/ijdb.052116mz

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  18 in total

1.  Investigation of the 22q11.2 candidate region in patients with midline facial defects with hypertelorism.

Authors:  M Simioni; E Lopes Freitas; T Paiva Vieira; I Lopes-Cendes; V Lúcia Gil-da-Silva-Lopes
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

Review 2.  Cranial neural crest cells on the move: their roles in craniofacial development.

Authors:  Dwight R Cordero; Samantha Brugmann; Yvonne Chu; Ruchi Bajpai; Maryam Jame; Jill A Helms
Journal:  Am J Med Genet A       Date:  2010-12-10       Impact factor: 2.802

Review 3.  Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndrome.

Authors:  Shan Gao; Xiao Li; Brad A Amendt
Journal:  Curr Allergy Asthma Rep       Date:  2013-12       Impact factor: 4.806

4.  Org-1, the Drosophila ortholog of Tbx1, is a direct activator of known identity genes during muscle specification.

Authors:  Christoph Schaub; Hideyuki Nagaso; Hong Jin; Manfred Frasch
Journal:  Development       Date:  2012-03       Impact factor: 6.868

5.  Tbx1 regulates oral epithelial adhesion and palatal development.

Authors:  Noriko Funato; Masataka Nakamura; James A Richardson; Deepak Srivastava; Hiromi Yanagisawa
Journal:  Hum Mol Genet       Date:  2012-02-27       Impact factor: 6.150

6.  Tbx1 is necessary for palatal elongation and elevation.

Authors:  Steven Goudy; Amy Law; Gabriela Sanchez; H Scott Baldwin; Christopher Brown
Journal:  Mech Dev       Date:  2010-03-07       Impact factor: 1.882

7.  BMPs and FGFs target Notch signalling via jagged 2 to regulate tooth morphogenesis and cytodifferentiation.

Authors:  Thimios A Mitsiadis; Daniel Graf; Hansueli Luder; Thomas Gridley; Gilles Bluteau
Journal:  Development       Date:  2010-08-04       Impact factor: 6.868

8.  Tbx1 regulates progenitor cell proliferation in the dental epithelium by modulating Pitx2 activation of p21.

Authors:  Huojun Cao; Sergio Florez; Melanie Amen; Tuong Huynh; Ziedonis Skobe; Antonio Baldini; Brad A Amendt
Journal:  Dev Biol       Date:  2010-09-15       Impact factor: 3.582

9.  Enamel-free teeth: Tbx1 deletion affects amelogenesis in rodent incisors.

Authors:  Javier Catón; Hans-Ulrich Luder; Maria Zoupa; Matthew Bradman; Gilles Bluteau; Abigail S Tucker; Ophir Klein; Thimios A Mitsiadis
Journal:  Dev Biol       Date:  2009-02-20       Impact factor: 3.582

10.  Candidate EDA targets revealed by expression profiling of primary keratinocytes from Tabby mutant mice.

Authors:  Diana Esibizione; Chang-Yi Cui; David Schlessinger
Journal:  Gene       Date:  2008-09-24       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.